These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38847551)

  • 1. Single-cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation.
    Declercq M; Treps L; Geldhof V; Conchinha NV; de Rooij LPMH; Subramanian A; Feyeux M; Cotinat M; Boeckx B; Vinckier S; Dupont L; Vermeulen F; Boon M; Proesmans M; Libbrecht L; Pirenne J; Monbaliu D; Jochmans I; Dewerchin M; Eelen G; Roskams T; Verleden S; Lambrechts D; Carmeliet P; Witters P
    Liver Int; 2024 Jun; ():. PubMed ID: 38847551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
    Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
    J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.
    Hernández-Gea V; Campreciós G; Betancourt F; Pérez-Campuzano V; Seijo S; Díaz A; Gallego-Durán R; Olivas P; Orts L; Magaz M; Baiges A; Turon F; Sidorova J; Romero-Gómez M; Lozano JJ; García-Pagán JC
    J Hepatol; 2021 Oct; 75(4):924-934. PubMed ID: 34052252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis.
    Su T; Yang Y; Lai S; Jeong J; Jung Y; McConnell M; Utsumi T; Iwakiri Y
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1139-1161. PubMed ID: 33340713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis.
    Stonebraker JR; Pace RG; Gallins PJ; Dang H; Aksit MA; Faino AV; Gordon WW; MacParland S; Bamshad MJ; Gibson RL; Cutting GR; Durie PR; Wright FA; Zhou YH; Blackman SM; O'Neal WK; Ling SC; Knowles MR
    Hepatology; 2024 Mar; ():. PubMed ID: 38536042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
    Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
    Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
    Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
    PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
    Poetter-Lang S; Staufer K; Baltzer P; Tamandl D; Muin D; Bastati N; Halilbasic E; Hodge JC; Trauner M; Kazemi-Shirazi L; Ba-Ssalamah A
    Eur Radiol; 2019 Feb; 29(2):1048-1058. PubMed ID: 30054796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modifiers of liver disease in cystic fibrosis.
    Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
    JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
    Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
    PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
    Squirell E; Lockyer J
    Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.